Ervebo, an Ebola vaccine from Merck, received marketing approval from the European Commission today (November 11), marking the first such vaccine to reach the world’s markets. (source: the-scientist.com)
(No Ratings Yet)
Loading...
Ervebo, an Ebola vaccine from Merck, received marketing approval from the European Commission today (November 11), marking the first such vaccine to reach the world’s markets. (source: the-scientist.com)
(No Ratings Yet)Loading...
